ATE424412T1 - Verbindungen mit wachstumshormon-freisetzenden eigenschaften - Google Patents
Verbindungen mit wachstumshormon-freisetzenden eigenschaftenInfo
- Publication number
- ATE424412T1 ATE424412T1 AT96941591T AT96941591T ATE424412T1 AT E424412 T1 ATE424412 T1 AT E424412T1 AT 96941591 T AT96941591 T AT 96941591T AT 96941591 T AT96941591 T AT 96941591T AT E424412 T1 ATE424412 T1 AT E424412T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- growth hormone
- sup
- independently
- hormone releasing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B41—PRINTING; LINING MACHINES; TYPEWRITERS; STAMPS
- B41J—TYPEWRITERS; SELECTIVE PRINTING MECHANISMS, i.e. MECHANISMS PRINTING OTHERWISE THAN FROM A FORME; CORRECTION OF TYPOGRAPHICAL ERRORS
- B41J19/00—Character- or line-spacing mechanisms
- B41J19/18—Character-spacing or back-spacing mechanisms; Carriage return or release devices therefor
- B41J19/20—Positive-feed character-spacing mechanisms
- B41J19/202—Drive control means for carriage movement
- B41J19/205—Position or speed detectors therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/0606—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing heteroatoms not provided for by C07K5/06086 - C07K5/06139, e.g. Ser, Met, Cys, Thr
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Obesity (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK146295 | 1995-12-22 | ||
DK69896 | 1996-06-25 | ||
US2206296P | 1996-07-22 | 1996-07-22 | |
DK81296 | 1996-07-24 | ||
DK124896 | 1996-11-06 | ||
US08/769,020 US5977178A (en) | 1995-12-22 | 1996-12-18 | Compounds with growth hormone releasing properties |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE424412T1 true ATE424412T1 (de) | 2009-03-15 |
Family
ID=27545172
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96941591T ATE424412T1 (de) | 1995-12-22 | 1996-12-16 | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
Country Status (18)
Country | Link |
---|---|
US (4) | US5977178A (de) |
EP (1) | EP0869974B1 (de) |
JP (2) | JP3701686B2 (de) |
CN (1) | CN1211991A (de) |
AT (1) | ATE424412T1 (de) |
AU (1) | AU715856B2 (de) |
BR (1) | BR9612275A (de) |
CA (1) | CA2239711A1 (de) |
CZ (1) | CZ195098A3 (de) |
DE (1) | DE69637855D1 (de) |
ES (1) | ES2323159T3 (de) |
HU (1) | HUP9802580A3 (de) |
IL (1) | IL124702A0 (de) |
MX (1) | MX9804830A (de) |
NO (1) | NO982872L (de) |
PL (1) | PL327227A1 (de) |
TW (1) | TW480248B (de) |
WO (1) | WO1997023508A1 (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69633003T2 (de) | 1995-01-27 | 2005-08-18 | Novo Nordisk A/S | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
ATE424412T1 (de) * | 1995-12-22 | 2009-03-15 | Novo Nordisk As | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
US5922770A (en) * | 1996-07-22 | 1999-07-13 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US6117841A (en) * | 1997-05-30 | 2000-09-12 | Warner-Lambert Company | Substituted peptidylamine calcium channel blockers |
US6127341A (en) * | 1997-06-20 | 2000-10-03 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
WO1998058950A1 (en) | 1997-06-20 | 1998-12-30 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
US6083908A (en) * | 1998-01-16 | 2000-07-04 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
DE69921611T2 (de) * | 1998-01-16 | 2005-11-03 | Novo Nordisk A/S | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
US6281247B1 (en) | 1998-03-03 | 2001-08-28 | Novo Nordisk A/S | Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide |
CN1291994A (zh) * | 1998-03-03 | 2001-04-18 | 诺沃挪第克公司 | 新的(2e)-5-氨基-5-甲基已-2-烯酸n-甲基-n-((1r)-1-(n-甲基-n-(1r)-1-(甲基氨基甲酰基)-2-苯2基氨基甲酰基-2-(2-萘基)2基酰胺的盐 |
US6784158B1 (en) * | 1998-06-09 | 2004-08-31 | Novo Nordisk A/S | Method for preparing a compound with growth hormone releasing properties |
WO1999067235A1 (fr) * | 1998-06-25 | 1999-12-29 | Sumitomo Pharmaceuticals Co., Ltd. | Composes cycliques a cinq elements |
EP1100824B1 (de) * | 1998-06-30 | 2011-03-02 | Novo Nordisk A/S | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
US6919315B1 (en) | 1998-06-30 | 2005-07-19 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
CN1325408A (zh) * | 1998-11-03 | 2001-12-05 | 诺沃挪第克公司 | 具有生长激素释放特性的化合物 |
US6566337B1 (en) | 1998-11-03 | 2003-05-20 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU759022B2 (en) | 1999-02-18 | 2003-04-03 | Kaken Pharmaceutical Co., Ltd. | Novel amide derivatives as growth hormone secretagogues |
US6518292B1 (en) * | 1999-03-12 | 2003-02-11 | Bristol-Myers Squibb Co. | Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
WO2000064845A1 (fr) * | 1999-04-22 | 2000-11-02 | Sankyo Company, Limited | Cetoamides porteurs de resine et leur procede de preparation |
AU6913700A (en) * | 1999-08-18 | 2001-03-13 | Schering Aktiengesellschaft | Piperidine and pyrrolidine derivatives displaying neuronal activity |
US20010020012A1 (en) * | 2000-02-01 | 2001-09-06 | Andersen Maibritt Bansholm | Use of compounds for the regulation of food intake |
EP1159964B1 (de) | 2000-05-31 | 2009-10-28 | Pfizer Products Inc. | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
US7425537B2 (en) * | 2000-08-22 | 2008-09-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | SH2 domain binding inhibitors |
IL163666A0 (en) | 2002-02-22 | 2005-12-18 | New River Pharmaceuticals Inc | Active agent delivery systems and methods for protecting and administering active agents |
AU2003265398A1 (en) * | 2002-08-09 | 2004-02-25 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds and methods to modulate coagulation |
MY139563A (en) * | 2002-09-04 | 2009-10-30 | Bristol Myers Squibb Co | Heterocyclic aromatic compounds useful as growth hormone secretagogues |
EP1407779A1 (de) | 2002-10-10 | 2004-04-14 | Gastrotech A/S | Verwendung von Ghrelin zur Behandlung von vermindertem Körpergewicht und Körperfett in Individuen mit Gastrektomie |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
US7501538B2 (en) | 2003-08-08 | 2009-03-10 | Transtech Pharma, Inc. | Aryl and heteroaryl compounds, compositions and methods of use |
US7208601B2 (en) * | 2003-08-08 | 2007-04-24 | Mjalli Adnan M M | Aryl and heteroaryl compounds, compositions, and methods of use |
WO2005027913A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue |
WO2005097261A1 (en) * | 2004-03-30 | 2005-10-20 | Sapphire Therapeutics, Inc. | Method of reducing c-reactive protein using growth hormone secretagogues |
US20070191283A1 (en) * | 2004-08-12 | 2007-08-16 | Rejuvenon Corporation | Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues |
EP1757290A1 (de) | 2005-08-16 | 2007-02-28 | Zentaris GmbH | Triazolderivate als Liganden der Wachstumshormonrezeptoren |
CU23558A1 (es) | 2006-02-28 | 2010-07-20 | Ct Ingenieria Genetica Biotech | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
EP2118123B1 (de) | 2007-01-31 | 2015-10-14 | Dana-Farber Cancer Institute, Inc. | Stabilisierte p53-peptide und deren verwendungen |
EA200901077A1 (ru) | 2007-02-09 | 2010-04-30 | Транзим Фарма, Инк. | Макроциклические модуляторы грелинового рецептора и их применение |
JP2010518158A (ja) * | 2007-02-13 | 2010-05-27 | ヘルシン セラピューティクス(ユー.エス.),インコーポレイティド | 成長ホルモン分泌促進物質を用いた細胞増殖性障害の治療方法 |
WO2008121767A2 (en) | 2007-03-28 | 2008-10-09 | President And Fellows Of Harvard College | Stitched polypeptides |
TWI429436B (zh) * | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
WO2010009327A1 (en) | 2008-07-17 | 2010-01-21 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Compounds for the treatment of pathologies associated with aging and degenerative disorders |
WO2010009389A1 (en) * | 2008-07-17 | 2010-01-21 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Use of targeted nitroxide agents in preventing, mitigating and treating radiation injury |
UA105657C2 (uk) * | 2009-02-27 | 2014-06-10 | Хелсінн Терапьютікс (Ю.Ес.), Інк. | Поліпшені способи лікування мігрені на основі анамореліну |
US8748369B2 (en) | 2009-06-05 | 2014-06-10 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Use of targeted nitroxide agents in bone healing |
WO2012021876A2 (en) | 2010-08-13 | 2012-02-16 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
EP2431035A1 (de) | 2010-09-16 | 2012-03-21 | Æterna Zentaris GmbH | Neue Triazolderivate mit verbesserter Rezeptoraktivität und Bioverfügbarkeitseigenschaften als Ghrelin-Antagonisten der Wachstumshormon-Sekretagogum-Rezeptoren |
WO2013013188A1 (en) | 2011-07-21 | 2013-01-24 | Tolero Pharmaceuticals, Inc. | Heterocyclic protein kinase inhibitors |
AU2012326026B2 (en) | 2011-10-18 | 2017-04-13 | Aileron Therapeutics, Inc. | Peptidomimetic macrocyles |
KR102112373B1 (ko) | 2012-02-15 | 2020-05-18 | 에일러론 테라퓨틱스 인코포레이티드 | 펩티드모방체 마크로사이클 |
US8987414B2 (en) | 2012-02-15 | 2015-03-24 | Aileron Therapeutics, Inc. | Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
SG11201503052RA (en) | 2012-11-01 | 2015-05-28 | Aileron Therapeutics Inc | Disubstituted amino acids and methods of preparation and use thereof |
US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
WO2016049359A1 (en) | 2014-09-24 | 2016-03-31 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
AU2016235424A1 (en) | 2015-03-20 | 2017-10-05 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles and uses thereof |
US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
MX2021009371A (es) | 2019-02-12 | 2021-09-10 | Sumitomo Pharma Oncology Inc | Formulaciones que comprenden inhibidores de proteina cinasa heterociclicos. |
CN112724052B (zh) * | 2021-01-21 | 2021-09-07 | 南京艾美斐生物医药科技有限公司 | 一种gpr101蛋白受体抑制剂及其制备和应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0663834A4 (de) * | 1992-09-25 | 1996-01-24 | Smithkline Beecham Corp | Wachstumshormon freisetzende peptide. |
BR9408377A (pt) * | 1993-12-23 | 1997-08-19 | Novo Nordisk As | Composto composição farmacêutica processo para estimular a liberação de hormônio de crescimento da pituitária e uso do composto |
DE4421052A1 (de) * | 1994-06-17 | 1995-12-21 | Basf Ag | Neue Thrombininhibitoren, ihre Herstellung und Verwendung |
US5798337A (en) * | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
DE69633003T2 (de) * | 1995-01-27 | 2005-08-18 | Novo Nordisk A/S | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
ATE424412T1 (de) * | 1995-12-22 | 2009-03-15 | Novo Nordisk As | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
-
1996
- 1996-12-16 AT AT96941591T patent/ATE424412T1/de not_active IP Right Cessation
- 1996-12-16 IL IL12470296A patent/IL124702A0/xx unknown
- 1996-12-16 PL PL96327227A patent/PL327227A1/xx unknown
- 1996-12-16 HU HU9802580A patent/HUP9802580A3/hu unknown
- 1996-12-16 EP EP96941591A patent/EP0869974B1/de not_active Expired - Lifetime
- 1996-12-16 BR BR9612275A patent/BR9612275A/pt not_active IP Right Cessation
- 1996-12-16 AU AU10929/97A patent/AU715856B2/en not_active Ceased
- 1996-12-16 CA CA002239711A patent/CA2239711A1/en not_active Abandoned
- 1996-12-16 CZ CZ981950A patent/CZ195098A3/cs unknown
- 1996-12-16 DE DE69637855T patent/DE69637855D1/de not_active Expired - Lifetime
- 1996-12-16 ES ES96941591T patent/ES2323159T3/es not_active Expired - Lifetime
- 1996-12-16 CN CN96199770A patent/CN1211991A/zh active Pending
- 1996-12-16 WO PCT/DK1996/000529 patent/WO1997023508A1/en not_active Application Discontinuation
- 1996-12-16 JP JP52323097A patent/JP3701686B2/ja not_active Expired - Fee Related
- 1996-12-18 US US08/769,020 patent/US5977178A/en not_active Expired - Lifetime
-
1997
- 1997-01-08 TW TW086100130A patent/TW480248B/zh not_active IP Right Cessation
-
1998
- 1998-06-16 MX MX9804830A patent/MX9804830A/es not_active IP Right Cessation
- 1998-06-19 NO NO982872A patent/NO982872L/no not_active Application Discontinuation
- 1998-12-21 US US09/218,686 patent/US6127391A/en not_active Expired - Lifetime
-
1999
- 1999-11-19 JP JP32892999A patent/JP4130519B2/ja not_active Expired - Fee Related
-
2000
- 2000-03-23 US US09/534,135 patent/US6555570B2/en not_active Expired - Fee Related
-
2002
- 2002-02-05 US US10/067,895 patent/US6939880B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2239711A1 (en) | 1997-07-03 |
AU715856B2 (en) | 2000-02-10 |
US6939880B2 (en) | 2005-09-06 |
US20030055261A1 (en) | 2003-03-20 |
MX9804830A (es) | 1998-09-30 |
JP2000143613A (ja) | 2000-05-26 |
IL124702A0 (en) | 1998-12-06 |
HUP9802580A3 (en) | 1999-03-29 |
PL327227A1 (en) | 1998-12-07 |
US6555570B2 (en) | 2003-04-29 |
DE69637855D1 (de) | 2009-04-16 |
BR9612275A (pt) | 1999-07-13 |
JPH11209336A (ja) | 1999-08-03 |
US6127391A (en) | 2000-10-03 |
WO1997023508A1 (en) | 1997-07-03 |
JP4130519B2 (ja) | 2008-08-06 |
AU1092997A (en) | 1997-07-17 |
EP0869974B1 (de) | 2009-03-04 |
JP3701686B2 (ja) | 2005-10-05 |
HUP9802580A2 (hu) | 1999-02-01 |
US20030040483A1 (en) | 2003-02-27 |
EP0869974A1 (de) | 1998-10-14 |
JPH11501054A (ja) | 1999-01-26 |
ES2323159T3 (es) | 2009-07-07 |
US5977178A (en) | 1999-11-02 |
TW480248B (en) | 2002-03-21 |
NO982872D0 (no) | 1998-06-19 |
CN1211991A (zh) | 1999-03-24 |
CZ195098A3 (cs) | 1998-10-14 |
NO982872L (no) | 1998-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE424412T1 (de) | Verbindungen mit wachstumshormon-freisetzenden eigenschaften | |
ITMI932113A1 (it) | Oligopeptidi ad attivita' fungicida | |
FR2662301B1 (fr) | Element emetteur d'electrons. | |
IT1295933B1 (it) | 2-(2'-idrossifenil)benzotriazoli e procedimento per la loro preparazione | |
DE69103945D1 (de) | Cyclohexapeptidverbindung. | |
IT9022538A0 (it) | Copoliesteri aventi una migliorata combinazione di proprieta'. | |
EP0569141A3 (de) | Methode zur Hemmung des Wachstums von multidrugresistenten Tumoren durch Antikörper. | |
DK1073447T3 (da) | N1-modificerede glycopeptider | |
ITTO910541A1 (it) | Rivestimento impermeabilizzante, particolarmente per l'eliminazione di infiltrazioni | |
ITRM930146A0 (it) | Composti fosfonito-hals dotati di proprieta' stabilizzati alla luce. | |
FR2662728B1 (fr) | Support de faux-planchers pour salles techniques, notamment salles d'informatique. | |
MY115467A (en) | Compounds with growth harmone releasing properties | |
RU95114858A (ru) | Новый пептидный фрагмент, обладающий биологической активностью инсулина | |
GR1001405B (el) | Ενώσεις 2-πιπεραζινόνης και η παραγωγή και η χρησιμοποίηση αυτών. | |
NO910643D0 (no) | Veksthormon-lignende glycoproteiner. | |
FR2707134B1 (fr) | Structure support de godets d'horticulture. | |
RU96108617A (ru) | Пептид, обладающий иммуносупрессивным свойством | |
IT9000549U1 (it) | Supporto per l'avvolgimento di bobine di filo. | |
NO941817L (no) | Syntese av trisyklo[3.3.1.13,7Ådec-2-yl[R-(R*,R*)Å-3-(1H-indol-3-yl-metyl)-3-metyl-4,9-dioxo-7,11-difenyl-10-oksa-2,5,8-triaza-undekanat | |
IT224900Z2 (it) | Supporto per l'applicazione di una unita' luminosa ad elementi filiformi, quale una lenza. | |
ITFI930047V0 (it) | Supporto con ripiani a piu' livelli per la presentazione di dolci od altro. | |
SE9500500D0 (sv) | Inhibtion of the growth of E. coli | |
FI902353A (fi) | Biologiskt foerebyggande av foeroekning av skadedjur genom tillsaettning av hormonaliska laekemedel i foer varje djur saeregen betestyp. | |
FI911678A0 (fi) | Foerfarande foer bildande av en hiss' hastighetsreferens. | |
FI913161A0 (fi) | Foerfarande foer framstaellning av n-(3',4'-dimetoxikinnamoyl) antranilsyra. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |